Evidence map›Paper›PMID 39993193›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

RORγt-expressing dendritic cells are functionally versatile and evolutionarily conserved antigen-presenting cells.

Hamsa Narasimhan, Maria L Richter, Ramin Shakiba, Nikos E Papaioannou, Christina Stehle, Kaushikk Ravi Rengarajan, Isabel Ulmert, Arek Kendirli, Clara de la Rosa, Pin-Yu Kuo and 20 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. ACY-1215 ameliorates experimental colitis by inhibiting dendritic cell maturation and Th1/Th17 responses.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. RORγtNature communications · 2026
    Article
  11. RORγtScience immunology · 2026
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Hamsa NarasimhanInstitute for Immunology, Biomedical Center Munich, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Maria L RichterBiomedical Center, Physiological Chemistry, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Ramin ShakibaInstitute for Immunology, Biomedical Center Munich, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Nikos E PapaioannouBiomedical Center, Institute of Cardiovascular Physiology and Pathophysiology, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Christina StehleInstitute for Medical Immunology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin 10117, Germany.
Kaushikk Ravi RengarajanInstitute for Immunology, Biomedical Center Munich, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Isabel UlmertSection for Experimental and Translational Immunology, Institute for Health Technology, Technical University of Denmark, Kongens Lyngby 2800, Denmark.
Arek KendirliInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Clara de la RosaInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Pin-Yu KuoInstitute for Immunology, Biomedical Center Munich, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Abigail AltmanMolecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, Lund 221 84, Sweden.ORCID 0009-0002-9692-2976
Philipp MünchInstitute for Molecular Medicine and Research Center for Immunotherapy (Forschungszentrum für Immuntherapie), University Medical Center Johannes Gutenberg-University Mainz, Mainz 55131, Germany.ORCID 0009-0004-1289-6833
Saba MahboubiInstitute for Molecular Medicine and Research Center for Immunotherapy (Forschungszentrum für Immuntherapie), University Medical Center Johannes Gutenberg-University Mainz, Mainz 55131, Germany.ORCID 0000-0001-9029-8784
Vanessa KüntzelBiomedical Center, Institute of Cardiovascular Physiology and Pathophysiology, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Amina SayedInstitute for Immunology, Biomedical Center Munich, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Eva-Lena StangeInstitute of Medical Microbiology, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen 52074, Germany.ORCID 0000-0001-8277-0663
Jonas PesInstitute of Medical Microbiology, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen 52074, Germany.
Alina Ulezko AntonovaDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.
Carlos-Filipe PereiraMolecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, Lund 221 84, Sweden.ORCID 0000-0002-9724-1382
Ludger KleinInstitute for Immunology, Biomedical Center Munich, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Diana DudziakInstitute of Immunology, Jena University Hospital of the Friedrich-Schiller-University, Jena 07747, Germany.ORCID 0000-0001-9358-134X
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.ORCID 0000-0001-5222-4987
Natalia TorowInstitute of Medical Microbiology, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen 52074, Germany.ORCID 0000-0003-3013-8724
Mathias W HornefInstitute of Medical Microbiology, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen 52074, Germany.ORCID 0000-0001-6096-9110
Björn E ClausenInstitute for Molecular Medicine and Research Center for Immunotherapy (Forschungszentrum für Immuntherapie), University Medical Center Johannes Gutenberg-University Mainz, Mainz 55131, Germany.ORCID 0000-0002-2484-7842
Martin KerschensteinerInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Katharina LahlSection for Experimental and Translational Immunology, Institute for Health Technology, Technical University of Denmark, Kongens Lyngby 2800, Denmark.
Chiara RomagnaniInstitute for Medical Immunology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin 10117, Germany.
Maria Colomé-TatchéBiomedical Center, Physiological Chemistry, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.
Barbara U SchramlInstitute for Immunology, Biomedical Center Munich, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried 82152, Germany.ORCID 0000-0002-5801-0151

Funding

Deutsche Forschungsgemeinschaft (DFG) CRC1292/2-TP20 (Project Nr. 318346496)Deutsche Forschungsgemeinschaft (DFG) DU548/6-1 (project number 431402787)Deutsche Forschungsgemeinschaft (DFG) FOR2599 (project P03 SCHR 1444/2-1)Deutsche Forschungsgemeinschaft (DFG) SFB 1335/P08 - Project number 360372040Deutsche Forschungsgemeinschaft (DFG) TRR355/1-A09 (Project Nr. 490846870)Deutsche Forschungsgemeinschaft (DFG) TRR 359 - Project number 491676693Deutsche Forschungsgemeinschaft (DFG) TRR 374/1 2024 TP B07 (project number 509149993)EC | ERC | HORIZON EUROPE European Research Council (ERC) ERC-2016-STG-715182
6 · The paper itself

Abstract

Conventional dendritic cells (cDCs) are potent antigen-presenting cells (APCs) that integrate signals from their environment allowing them to direct situation-adapted immunity. Thereby they harbor great potential for being targeted in vaccination, autoimmunity, and cancer. Here, we use fate mapping, functional analyses, and comparative cross-species transcriptomics to show that RORγt

Indexed as

Antigen-Presenting CellsDendritic CellsNuclear Receptor Subfamily 1, Group F, Member 3AIRE ProteinAnimalsCD4-Positive T-LymphocytesHumansMiceMice, Inbred C57BLTranscription FactorsAIRE ProteinNuclear Receptor Subfamily 1, Group F, Member 3Transcription FactorsAIREantigen presenting cellsdendritic cellsinnate lymphocytesRORγt

Identifiers

PMID39993193
PMCPMC11892598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.